Dr. Drachman is Chief Medical Officer and Executive Vice President of Research and Development of Seattle Genetics where he leads the company’s clinical and research teams. Dr. Drachman previously served as Senior Vice President, Research and Translational Medicine of Seattle Genetics. Prior, Dr. Drachman served as a faculty member in the Hematology Division, Department of Medicine at the University of Washington in Seattle, and as a Senior Investigator in the Division of Research and Education at the Puget Sound Blood Center. Dr. Drachman received a B.A. in Biochemistry from Harvard University and an M.D. from Harvard Medical School. He completed his residency in Internal Medicine and fellowship in Medical Oncology at the University of Washington.